These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11896620)

  • 1. Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia.
    Gasco M; Sullivan A; Repellin C; Brooks L; Farrell PJ; Tidy JA; Dunne B; Gusterson B; Evans DJ; Crook T
    Oncogene; 2002 Mar; 21(12):1876-81. PubMed ID: 11896620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity.
    Gasco M; Bell AK; Heath V; Sullivan A; Smith P; Hiller L; Yulug I; Numico G; Merlano M; Farrell PJ; Tavassoli M; Gusterson B; Crook T
    Cancer Res; 2002 Apr; 62(7):2072-6. PubMed ID: 11929827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.
    van de Nieuwenhof HP; van Kempen LC; de Hullu JA; Bekkers RL; Bulten J; Melchers WJ; Massuger LF
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2061-7. PubMed ID: 19567503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma].
    Koscielny S; V Eggeling F; Dahse R
    Laryngorhinootologie; 2004 Jun; 83(6):374-80. PubMed ID: 15197677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation and intratumoural heterogeneity of 14-3-3 sigma in oral cancer.
    Bhawal UK; Tsukinoki K; Sasahira T; Sato F; Mori Y; Muto N; Sugiyama M; Kuniyasu H
    Oncol Rep; 2007 Oct; 18(4):817-24. PubMed ID: 17786341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus.
    Lerma E; Esteller M; Herman JG; Prat J
    Hum Pathol; 2002 Nov; 33(11):1120-5. PubMed ID: 12454817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of the CDKN2A and the p53 tumour suppressor genes in external genital carcinomas and their precursors.
    Soufir N; Queille S; Liboutet M; Thibaudeau O; Bachelier F; Delestaing G; Balloy BC; Breuer J; Janin A; Dubertret L; Vilmer C; Basset-Seguin N
    Br J Dermatol; 2007 Mar; 156(3):448-53. PubMed ID: 17300232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant transformation of mature cystic teratoma to squamous cell carcinoma involves altered expression of p53- and p16/Rb-dependent cell cycle regulator proteins.
    Iwasa A; Oda Y; Kurihara S; Ohishi Y; Yasunaga M; Nishimura I; Takagi E; Kobayashi H; Wake N; Tsuneyoshi M
    Pathol Int; 2008 Dec; 58(12):757-64. PubMed ID: 19067849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of 14-3-3 sigma protein in various histological subtypes of uterine cervical cancers.
    Sano T; Shimooka H; Weixa P; Segawa A; Jian Z; Motegi A; Nakayama H; Oyama T; Nakajima T
    Pathol Int; 2004 Oct; 54(10):743-50. PubMed ID: 15482563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The absence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to the HPV-independent pathway as the causative agent for vulvar squamous cell carcinoma and its precursor simplex VIN in a young patient.
    Kruse AJ; Bottenberg MJ; Tosserams J; Slangen B; van Marion AM; van Trappen PO
    Int J Gynecol Pathol; 2008 Oct; 27(4):591-5. PubMed ID: 18753959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 protein expression in a population-based series of primary vulval squamous cell carcinoma and immediate adjacent field change.
    McConnell DT; Miller ID; Parkin DE; Murray GI
    Gynecol Oncol; 1997 Dec; 67(3):248-54. PubMed ID: 9441771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of loss of heterozygosity in vulval intraepithelial neoplasia (VIN) is associated with invasive vulval squamous cell carcinoma (VSCC).
    Rosenthal AN; Ryan A; Hopster D; Surentheran T; Jacobs IJ
    Int J Cancer; 2001 Dec; 94(6):896-900. PubMed ID: 11745496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression.
    Lodygin D; Diebold J; Hermeking H
    Oncogene; 2004 Dec; 23(56):9034-41. PubMed ID: 15489902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.
    Umbricht CB; Evron E; Gabrielson E; Ferguson A; Marks J; Sukumar S
    Oncogene; 2001 Jun; 20(26):3348-53. PubMed ID: 11423985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modes of silencing of p16 in development of esophageal squamous cell carcinoma.
    Tokugawa T; Sugihara H; Tani T; Hattori T
    Cancer Res; 2002 Sep; 62(17):4938-44. PubMed ID: 12208744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of allelic loss (LOH) in vulvar squamous carcinomas and adjacent noninvasive epithelia.
    Lin MC; Mutter GL; Trivijisilp P; Boynton KA; Sun D; Crum CP
    Am J Pathol; 1998 May; 152(5):1313-8. PubMed ID: 9588899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas.
    Wang Z; Tropè CG; Suo Z; Trøen G; Yang G; Nesland JM; Holm R
    BMC Cancer; 2008 Oct; 8():308. PubMed ID: 18950492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin.
    Tyler LN; Ai L; Zuo C; Fan CY; Smoller BR
    Mod Pathol; 2003 Jul; 16(7):660-4. PubMed ID: 12861061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.